ReviewActa obstetricia et gynecologica Scandinavica2026
The association between collagenopathies and the risk of spontaneous preterm birth: A systematic review with selective meta-analysis.
Review in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSpontaneous preterm birth (sPTB) remains a leading cause of neonatal morbidity and mortality. Inherited collagenopathies, including Ehlers-Danlos syndrome (EDS) and Marfan syndrome (MFS), may predispose to sPTB through impaired connective tissue integrity; however, the available evidence has not been systematically synthesized according to collagenopathy subtype. We aimed to evaluate the association between inherited collagenopathies and sPTB through a systematic review, undertaking quantitative synthesis only where clinically appropriate and methodologically comparable. MATERIAL AND
methodsThis systematic review followed PRISMA 2020 guidelines and was prospectively registered in PROSPERO (CRD420251021631). MEDLINE (PubMed), Embase (Ovid), Scopus, Web of Science, and the Cochrane Library were searched from inception to 30 April 2025. Observational studies comparing pregnancy outcomes in women with inherited collagenopathies and women without collagenopathies were eligible. The primary outcome was sPTB before 37 weeks' gestation. Findings were synthesized narratively according to collagenopathy subtype. Meta-analysis using a Mantel-Haenszel fixed-effect model was undertaken only for clinically comparable MFS studies.
resultsFourteen observational studies met the inclusion criteria. Four studies evaluated MFS, seven evaluated EDS, one assessed vascular EDS exclusively and two included mixed collagenopathy cohorts. Meta-analysis demonstrated that women with MFS had significantly higher odds of sPTB than controls (OR 2.71, 95% CI 2.23-3.30; p < 0.001; I
conclusionsInherited collagenopathies appear to be associated with an increased risk of sPTB, although the certainty of evidence differs across phenotypes. The strongest comparative evidence currently exists for MFS, whereas evidence for EDS syndrome remains limited by substantial clinical heterogeneity. These findings support phenotype-specific obstetric assessment and highlight the need for prospective studies with standardized subtype classification and outcome reporting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.